Kymera Therapeutics (KYMR) Price to Sales (2020 - 2026)
Kymera Therapeutics' (KYMR) Price to Sales came in at 90.41 for Q2 2026, up 31.3% from 68.87 a year earlier but down 32.0% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Price to Sales (2020 - 2026) Analysis & Trends
For FY2025, Kymera Therapeutics' Price to Sales stood at 161.38, up 191.0% from FY2024.
- In prior years, Kymera Therapeutics' Price to Sales was 55.46 in FY2024 (+208.0%), 18.01 in FY2023 (-38.6%), 29.34 in FY2022 (-34.7%) and 44.93 in FY2021 (+42.1%).
- Quarterly Price to Sales has run from a low of 16.45 in Q3 2023 to a high of 161.38 in Q4 2025 over five years.
- On a year-over-year basis, Price to Sales has increased in each of the last five quarters, with growth averaging 159.6% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q1 2026, with growth of 339.4%; the weakest was Q2 2022, with a decline of 47.2%.
- According to Business Quant data, Price to Sales for the three prior quarters was 132.98 (Q1 2026), 161.38 (Q4 2025) and 92.85 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Kymera Therapeutics | 8.89 Bn | 6.19 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.41 |
| Mar 31, 2026 | 132.98 |
| Dec 31, 2025 | 161.38 |
| Sep 30, 2025 | 92.85 |
| Jun 30, 2025 | 68.87 |
| Mar 31, 2025 | 30.26 |
| Dec 31, 2024 | 55.46 |
| Sep 30, 2024 | 35.00 |
| Jun 30, 2024 | 20.76 |
| Mar 31, 2024 | 31.06 |
| Dec 31, 2023 | 18.01 |
| Sep 30, 2023 | 16.45 |
| Jun 30, 2023 | 24.65 |
| Mar 31, 2023 | 35.09 |
| Dec 31, 2022 | 29.34 |
| Sep 30, 2022 | 25.93 |
| Jun 30, 2022 | 17.99 |
| Mar 31, 2022 | 34.31 |
| Dec 31, 2021 | 44.93 |
| Sep 30, 2021 | 42.80 |
API Access
Kymera Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();